Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × niraparib × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 65 Fallopian Tube Neoplasms 17 Breast Neoplasms 7 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Uterine Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Sarcoma 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Recurrence 1 Prostatic Diseases 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Platinum-resistant Ovarian Cancer 1 Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1 Ovarian Diseases 1 Ovarian Carcinosarcoma 1 Neutropenia 1 Nausea 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Paclitaxel 6 pembrolizumab 5 Carboplatin 4 liposomal doxorubicin 3 Gemcitabine 3 Cisplatin 3 Bevacizumab 3 trebananib 2 interferon gamma-1b 2 dostarlimab 2 catumaxomab 2 anlotinib 2 Topotecan 2 Radiotherapy, Intensity-Modulated 2 Ocoxin 2 Itraconazole 2 Hyperthermic Intraperitoneal Chemotherapy 2 Drug Therapy 2 Docetaxel 2 vistusertib 1 pertuzumab 1 peginterferon alfa-2b 1 olaparib 1 niraparib 1 nintedanib 1 lanreotide 1 enzastaurin 1 efineptakin alfa 1 durvalumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827353 2025-02-14

OVNI-B

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡